B. Riley lowered the firm’s price target on Biote (BTMD) to $9 from $10 and keeps a Buy rating on the shares. Biote’s Q4 revenue and AEBITDA ...

Q4 2024 Earnings Call Transcript March 12, 2025 biote Corp. beats earnings expectations. Reported EPS is $0.1, expectations ...

And as I think about the value of Biote, we've got fantastic products. So we've got testosterone pellets, we've got the B-glycemic balls, we've got BioteRx. And the way we're starting to form the ...

BioTE Corp (BTMD) reported its fourth-quarter 2024 earnings, revealing a slight miss on earnings per share (EPS) forecasts, which contributed to a negative market reaction. The company posted an ...

BioTE Corp (BTMD) reported its fourth-quarter 2024 earnings, revealing a slight miss on earnings per share (EPS) forecasts, which contributed to a negative market reaction. The company posted an EPS ...